GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Thoratec Corporation (THOR) [hlAlert]

Rating:
Market Perform
THOR

Thoratec Corporation (THOR) rated Market Perform with price target $63.50 by Northland Capital

Posted on: Wednesday,  Jul 22, 2015  10:25 AM ET by Northland Capital

Northland Capital rated Market Perform Thoratec Corporation (NASDAQ: THOR) on 07/22/2015. Previously Northland Capital rated Outperform Thoratec Corporation (NASDAQ: THOR) on
10/31/2013., when the stock price was $42.99. Since then, Thoratec Corporation has lost 46.41% as of 08/11/2014's recent price of $23.04.
If you would have followed the previous Northland Capital's recommendation on THOR, you would have lost 46.4% of your investment in 284 days.

Thoratec Corporation (Thoratec) is a manufacturer of mechanical circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets medical devices used for circulatory support. It also develops, manufactures and markets point-of-care diagnostic test systems and skin incision products. Thoratec operates in two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. The Company conducts business both in the United States and internationally.

Northland Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/22/2015 10:25 AM Hold
None
63.08 63.50
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD down  -37.04 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/11/2014 12:00 AM Hold
None
23.04
10/31/2013 1:25 PM Buy
None
42.99 46.00
8/1/2013 8:25 AM Buy
None
36.09 42.00
2/8/2013 8:25 AM Hold
None
36.55

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy